Elastography for the non-invasive assessment of liver disease: Limitations and future developments

Gut

Volumn 58, Issue 2, 2009, Pages 157-160

  Vizzutti, Francesco ^a   Arena, Umberto ^a   Marra, Fabio ^a   Pinzani, Massimo ^a,b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CHRONIC LIVER DISEASE; COMMON BILE DUCT STONE; ELASTOGRAPHY; FUTUROLOGY; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FORECASTING; HUMANS; LIVER; LIVER DISEASES; STATISTICS AS TOPIC;

EID: 58849116815     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.156489     Document Type: Review

References (44)

1. Menghini G. One-second needle biopsy of the liver. Gastroenterology 1958;35:190-9.
2. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
3. Bedossa P, Poynard T. An algorithm for the grading of activity of chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93.
4. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
5. Regev A, Berho M, Jeffers LJ, ef al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-8.
6. Ratziu V, Charlotte F, Heurtier A, ef al. Sampling variability of liver biopsy in non-alcoholic fatty liver disease. Gastroenterology 2005;128:1898-906.
7. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-57.
8. Manco M, Bedogni G, Marcellini M, ef al. Waist circumference correlates with liver fibrosis in children with non alcoholic steatohepatitis. Gut 2008;57:1283-7.
9. Nobili V, Vizzutti F, Arena U, ef al. Accuracy and reproducibility of transient elastography for thediagnosis of fibrosis in pediatric non-alcoholic steatohepatitis. Hepatology 2008;48:442-8.
10. Huwart L, Sempoux C, Vicaut E, ef al. Magnetic resonance elastography for noninvasive staging of liver fibrosis. Gastroenterology 2008;135:32-40.
11. Canión JA, Navasa M, Forns X. MR elastography to assess liver fibrosis. Radiology 2007;247:591-2.
12. Romero-Gómez M, Gómez-Gonzáles E, Madrazo A, ef al. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology 2008;47:810-6.
13. Sandrin L, Tanter M, Gennisson JL, ef al. Shear elasticity probe for soft tissues with 1D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control 2002;49:436-46.
14. Sandrin L, Fourquet B, Haquenoph JM, ef al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-13.
15. Roulot D, Czernichow S, Le Clésiau H. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008,48:606-13.
16. Fraquelli M, Rigamonti C, Casazza G, ef al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968-73.
17. Foucher J, Castera L, Bernard PH, ef al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006;18:411-2.
18. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54.
19. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403-8.
20. de Lédinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/Hepatitis C virus co-infected patients. J Acquir Immune Defic Syndr 2006;41:175-9.
21. Ganne-Carrié N, Ziol M, de Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver disease. Hepatology 2006;44:1511-7.
22. Arena U, Vizzutti F, Abraldes JG, et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008;57:1288-93.
23. Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290-7.
24. Pinzani M, Vizzutti F, Arena U, et al. Technology insight: non-invasive assessment of liver fibrosis by biochemical scores and elastography. Nature Clin Prac Gastroenterol Hepatol 2008;5:95- 106.
25. Rigamonti C, Donato MF, Fraquelli M, et al. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation. Gut 2008;57:821-7.
26. Carrion JA, Navasa M, Bosch J, et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006;12:1791-8.
27. Harada N, Soejima Y, Taketomi A, et al. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation 2008;85:69- 74.
28. Masaki N, Imamura M, Kikuchi Y, et al. Usefulness of elastometry in evaluating the extents of liver fibrosis in hemophliacs coinfected with hepatitis C virus and human immunodeficiency virus. Hepatol Res 2006;35:135-9.
29. Kazemi F, Kettaneh A, N'kontchou G, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006;45:230-5.
30. Rockey DC. Non invasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134:8-14.
31. Coco B, Olivieri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of aminotransferases. J Viral Hepatol 2006;14:360-9.
32. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47:380-4.
33. Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008;47:592-5.
34. National Institutes of Health. National Institute of Health Consensus Development Conference Statement: management of hepatitis C 2002 (June 10-12, 2002). Gastroenterology 2002;123:2082-99.
35. Ripoll C, Groszman R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481-8.
36. Garcia-Tsao G, Bosch J, Groszmann R. Portal hypertension and variceal bleeding - unresolved issue. Summary of an American Association for the Study of the Liver Diseases and European Association for the Study of the Liver single-topic conference. Hepatology 2008;47:1764-72.
37. Bosch J, Garcia-Pagan JC. Pathophysiology of portal hypertension and its complications. In: Bircher J, Benhamou JP, Mclntyre N, et al, eds. Oxford textbook of clinical hepatology. New York: Oxford University Press, 1999: 653-60.
38. Bosch J. Predictions from a hard liver. J Hepatol 2006;45:174-7.
39. Lee SS, Hadengue A, Moreau R, et al. Postprandial hemodynamic responses in patients with cirrhosis. Hepatology 1988;8:647-51.
40. Tsunoda T, Ohnishi K, Tanaka H. Portal hemodynamic responses after oral intake or glucose in patients with cirrhosis. Am J Gastroenterol 1988;83:398-403.
41. Kim KM, Choi WB, Park SH, et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol 2007;42:382-8.
42. Yoneda M, Mawatari H, Fujita K, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40:371-8.
43. Desks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004;329:168-9.
44. Guyatt G, Sackett DL, Haynes B. Evaluating diagnostic tests. In: Haynes B, Sackett DL, Guyatt G, Tulliez M, eds. Clinical epidemiology, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2006: 273-322.